Biological age reversal, epigenetic clocks, senolytics, and anti-aging interventions
669 articles
Review identifies taurine, betaine, α-ketoglutarate, and other naturally-produced compounds that may delay aging through multiple cellular pathways.
New research shows biological age markers can guide personalized aesthetic treatments that target aging at the molecular level.
Comprehensive review reveals how immunosenescence creates tumor-promoting environments and reduces treatment effectiveness in elderly cancer patients.
Comprehensive review examines rapamycin's anti-aging potential, revealing mixed results and significant safety considerations for off-label use.
New review examines senolytic drugs that target aging cells in bone tissue, revealing gaps between promising animal studies and human trials.
New review reveals how senescent cells both prevent and fuel cancer, opening doors to precision therapies targeting aging pathways.
Comprehensive review reveals how drugs that eliminate or modify senescent cells could revolutionize anti-aging medicine.
Autonomous AI system reanalyzed millions of studies to find 500+ interventions that reduce biological age, validating ouabain in mice.
Centenarians have 3x higher ACBP levels. Blocking this aging protein with antibodies prevents organ damage and cellular senescence.
New research explores how aging varies across organ systems using comprehensive molecular analysis to understand individual differences.
Comprehensive study reveals metabolic aging patterns across organs and identifies compounds that could slow aging processes.
Chronic exposure to low levels of chlorpyrifos pesticide causes telomere shortening and premature aging in fish populations.
